Jean-Michel Dogné to Aged
This is a "connection" page, showing publications Jean-Michel Dogné has written about Aged.
Connection Strength
0.036
-
Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498.
Score: 0.004
-
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021 07 14; 13(7).
Score: 0.004
-
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep; 27(9):1351.e5-1351.e7.
Score: 0.004
-
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin Chem Lab Med. 2021 04 27; 59(5):e179-e183.
Score: 0.004
-
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. Eur J Drug Metab Pharmacokinet. 2020 Dec; 45(6):703-713.
Score: 0.004
-
Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2021 04; 93(4):2262-2269.
Score: 0.004
-
Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 02; 93(2):803-811.
Score: 0.004
-
Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps. Br J Clin Pharmacol. 2021 02; 87(2):674-682.
Score: 0.004
-
Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study. Br J Clin Pharmacol. 2018 07; 84(7):1544-1556.
Score: 0.003